Temple Bar Investment Trust Plc
Interim Management Statement
for the quarter ended 31 March 2013
Objective
The Company's investment objective is to provide growth in income and capital
to achieve a long term total return greater than the benchmark FTSE All-share
Index, through investment primarily in UK securities. The Company's policy is
to invest in a broad spread of securities with typically the majority of the
portfolio selected from the constituents of the FTSE 350 Index.
Material Events and Transactions
During the quarter to March 2013, Temple Bar achieved an NAV total return of
16.7%. This compares with a total return of capital and income from the FTSE
All-Share Index of 10.3%. Temple Bar's long term track record remains very
good, having delivered a share price total return of 292.0% over the 10 years
to 31 March 2013 compared with a 175.3% return for the FTSE All-Share Index.
Central bankers worldwide have become increasingly confident of the need for
imaginative policy action and this has encouraged an almost Pavlovian reaction
amongst investors to buy equities. Whilst initially the underlying premise was
that these policy actions were positive for economic growth prospects, recently
investors appear to believe that such policy action simply results in equities
increasing in value. It is unclear why central bankers should be as confident
as they are given the events of the last decade have fooled them at every turn.
We remain concerned at the unintended consequences of their actions.
Portfolio activity has increased in recent months. Some large holdings such as
Unilever, Signet Jewelers and Travis Perkins have been reduced and the proceeds
switched into GlaxoSmithKline, Imperial Tobacco and Vodafone. The total holding
in Astra Zeneca was sold as our longer term concerns for the group's
profitability grew. We also participated in the Direct Line IPO. Whilst we
rarely invest in new issues we believed that an, ultimately, independent Direct
Line operating outside of its erstwhile owner, the Royal Bank of Scotland could
result in a number of operating efficiencies and consequently improve returns
to shareholders.
A final dividend of 22.0p per share was paid on 28 March 2013 to shareholders
on the register as at 15 March 2013. The total payment for the year ended 31
December 2012 was 36.65p per share.
Top Ten Holdings as at 31 March 2013
% total assets
GlaxoSmithKline PLC 7.73
HSBC Holdings PLC 7.45
Vodafone Group PLC 6.91
Signet Jewelers Ltd 6.55
Royal Dutch Shell PLC 6.54
Unilever PLC 4.78
Grafton Group PLC 4.67
BT Group PLC 4.15
Travis Perkins PLC 3.90
QinetiQ Group PLC 3.01
55.69
Financial Performance
Quarter to Year to
31 March 31 December
2013 2012
Total assets less current liabilities £744.58m £664.65m
NAV total return 16.7% 18.0%
Dividend yield 3.3% 3.7%
NAV per share (debt at book value) 1120.99p 992.86p
NAV per share (debt at market value) 1096.52p 969.00p
Price per share 1105p 1005p
(Premium) (debt at market value) (0.8)% (3.7)%
Discount/(premium) (debt at book value) 1.4% (1.2)%
FTSE All-Share Index total return 10.3% 12.3%
Note: The directors are not aware of any significant events or transactions
which have occurred between the date of the financial information and the date
of publication, which would have a material impact on the financial position of
the Company.
The net asset value is published on a daily basis and other useful background
information on the Company including downloads of published documentation such
as previous Annual Reports and Monthly Fact Sheets can be found at
www.templebarinvestments.co.uk.
Company Information
Launch date 1926
Year end 31 December
Results
Interim Announcement in July 2013
Final Announcement in February 2014
Dividend payments March, September
Price information Published in the Financial Times under `Investment
Companies'.
Contact
Martin Slade
Investec Asset Management Limited
Woolgate Exchange
25 Basinghall Street
London EC2V 5HA
Tel: +44 (0)20 7597 1942
J:\fund accounting\Temple Bar\2013\NAVs\03 Mar\Monthly\Interim ManagementStatement March 13v2.doc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.